Barriers to medication adherence in poorly controlled diabetes mellitus

Diabetes Educator

Volumn 34, Issue 4, 2008, Pages 692-697

  Odegard, Peggy Soule ^a   Gray, Shelly L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; STATISTICS;

ADULT; AGE OF ONSET; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PRESCRIPTIONS, DRUG; REGRESSION ANALYSIS;

EID: 47749091710     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721708320558     Document Type: Article

References (23)

1. Odegard PS, Goo A., Hummel J., Williams KL, Gray SL Caring for poorly controlled diabetes: a randomized pharmacist intervention. Ann Pharmacother. 2005 ; 39 (3). 433-440.
2. Morisky DE, Green LW, Levine DM Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 ; 24 (1). 67-74.
3. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 ; 37 (2). 113-124.
4. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention ; 2005.
5. Saaddine JB, Cadwell B., Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006 ; 144: 465-474.
6. Rhee MK, Slocum W., Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educ. 2005 ; 31 (2). 240-250.
7. Krapek K., King K., Warren SS, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmaco. 2004 ; 38: 1357-1362.
8. Schectman JM, Nadkarni MM, Voss JD The association between diabetes metabolic control and drug adherence in an indigent population. Diab Care. 2002 ; 25: 1015-1021.
9. Donnan PT, MacDonald TM, Morris AD, for the DARTS/MEMO Collaboration. Adherence to prescribed oral hypoglycemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002 ; 19: 279-282.
10. Evans JM, Donnan PT, Morris AD Adherence to oral hypoglycemic agents prior to insulin therapy in type 2 diabetes. Diabet Med. 2002 ; 19: 685-688.
11. Venturini F., Nichol MB, Sung JC, Bailey KL, Cody M., McCombs JS Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother. 1999 ; 33 (Mar): 281-288.
12. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet. 1997 ; 350 (Nov): 1505-1510.
13. Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CE Sulfonylurea pharmacotherapy regimen compliance in a Medicaid population: influence of age, gender, and race. Diabetes Educ. 1999 ; 25 (4). 531-538.
14. Newman KD, Weaver MT Insulin measurement and preparation among diabetic patients at a county hospital. Nurse Pract. 1994 ; 19 (3). 44-45, 48.
15. Hertz RP, Unger AN, Lustik AP Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005 ; 27 (7). 1064-1073.
16. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006 ; 166: 1836-1841.
17. American Diabetes Association. Direct and indirect costs of diabetes in the United States. Available at: http://www.diabetes.org/diabetes-statistics/ cost-of-diabetes-in-us.jsp. Accessed July 25, 2007.
18. Rubin RR Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005 ; 188 (5A). 27S - 34S.
19. Lin EH, Katon W., Von Korff M., et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diab Care. 2004 ; 27 (9). 2154-2160.
20. Paes AHP, Bakker A., Soe-Agnie CJ Impact of dosage frequency on patient compliance. Diab Care. 1997 ; 20 (10). 1512-1517.
21. Grant RW, Devita NG, Singer DE, Meigs JB Polypharmacy and medication adherence in patients with type 2 diabetes. Diab Care. 2003: 26 (5). 1408-1412.
22. Hartz A., Kent S., James P., Xu Y., Kelly M., Daly J. Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2006 ; 74: 227-232.
23. Richter A., Anton SE, Koch P., Dennett SL The impact of reducing dose frequency on health outcomes. Clin Therap. 2003 ; 25 (8). 2307-2335.